• share
• favorite_border

The Cancer Research Institute (CRI) has appointed Alicia Zhou, PhD, as its new Chief Executive Officer (CEO).

• share
• favorite_border

CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.

• share
• favorite_border

CRI awarded over $22 million to leading cancer immunotherapy researchers in the 2024 fiscal year, amounting to 64 awards at 42 institutions.

• share
• favorite_border

CRI has announced its new class of 2024 Scientists Taking Risks (STARs) grant recipients who are expert cancer immunotherapy researchers.

• share
• favorite_border

CRI helped commission a poll of oncologists who say that much more research is required to holistically tackle non-small cell lung cancer.

• share
• favorite_border

The Cancer Research Institute and Lance Kawaguchi with the #SouthPoleTrek4Cancer ring in the Nasdaq Stock Market Closing Bell.

• share
• favorite_border

CRI's 2023 Patient Immunotherapy Summit is now available on-demand for the benefit of cancer patients, families, caregivers, and scientists.

• share
• favorite_border

The Cancer Research Institute is proudly awarding Dr. Ananda Goldrath with the 2023 Fredrick W. Alt award for New Discoveries in Immunology.

• share
• favorite_border

Michael Berger, PhD, has been awarded a grant by The Israel Cancer Research Fund (ICRF) and the Cancer Research Institute (CRI).

• share
• favorite_border

The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research 

• share
• favorite_border

The Cancer Research Institute awarded $28.7 million in research grants and fellowships in the 2023 fiscal year ending June 30, 2023. In total, CRI distributed 73 awards that will advance cancer immunology research at 41 institutions in 10 countries. CRI grants were awarded to support projects involving a variety of immune-based approaches as well as the development of novel technologies that may help pave the way for the next generation of immunotherapies.

• share
• favorite_border

Fern Lazar, Managing Partner and Global Health Practice Leader at FINN Partners, was elected to the Cancer Research Institute’s Board of Trustees.

• share
• favorite_border

The Cancer Research Institute is honoring Dr. Tak Mak with the prestigious 2023 William B. Coley Award.

• share
• favorite_border

Global celebration of 11 years of discovery and lifesaving innovation in immuno-oncology

• share
• favorite_border

The immuno-oncology (IO) clinical trial landscape is shifting in new directions. While the number of total clinical trials is down, there are healthy signs of innovation.

• share
• favorite_border

Lance Kawaguchi, an internationally recognized executive leader and board member with over 25 years of global finance and banking experience, will be undertaking a monumental Trek to the South Pole in December 2023 to raise funds for several charities, including the Cancer Research Institute (CRI). Serving as a strategic advisor, he has pledged to lead a global effort to raise awareness and funds for CRI.

• share
• favorite_border

Free online event for cancer patients and caregivers featuring immunotherapy experts and patient advocates taking place Nov. 11-12, 2022.

• share
• favorite_border

The CRI-ICRF Clinic and Laboratory Integration Program (CLIP) Grant to Fund Promising Immunotherapy Research in Israel Is Awarded to Yifat Merbl, PhD, of the Weizmann Institute of Science.

• share
• favorite_border

The Cancer Research Institute (CRI), a nonprofit organization dedicated to harnessing the immune system’s power to control and potentially cure all types of cancer, will confer its prestigious 2022 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology on four scientists for their collective work that revealed the role of the pore-forming gasdermins in pyroptosis and promotion of anti-tumor immunity, setting the stage for targeting gasdermins in cancer therapeutics.

• share
• favorite_border

El Cancer Research Institute (CRI), una organización sin fines de lucro consagrada a aprovechar la capacidad del sistema inmunitario para combatir y potencialmente curar todos los tipos de cáncer, ofrecerá su segunda Conferencia Virtual CRI de Inmunoterapia para Pacientes con Cáncer, el 22 de septiembre de 2022, de 2 a 5 p. m. (hora del este).